Story

Symrise Q2 Organic Sales Growth of 4.5% Beats Forecasts

ENTHMSVIIDZHZH-TWJAKOHI
Jul 30, 20262 min read
Symrise Q2 Organic Sales Growth of 4.5% Beats Forecasts
Text size
Background

German flavor and fragrance manufacturer Symrise AG (XETRA:SY1) reported second-quarter organic sales growth of 4.5%, significantly outpacing analyst forecasts and signaling resilient demand in key markets. The company's performance was bolstered by strong results in its Taste, Nutrition & Health division and robust expansion in North America and the Asia Pacific region.

Quarterly Results Exceed Estimates

Symrise's Q2 growth was well above the consensus analyst expectation of 3.0%, according to company disclosures. Total sales and earnings for the period also came in ahead of projections.

  • Q2 Sales: Reached €1,290 million, compared to a consensus forecast of €1,257 million.
  • First-Half EBITDA: Came in at €553 million, which was 1% above the consensus of €545 million.
  • EBITDA Margin: Increased by 10 basis points year-over-year.

Segment and Regional Performance

The company's Taste, Nutrition & Health division was a key driver, posting organic sales growth of 4.9% on sales of €782 million. The Scent & Care division also delivered solid results, with organic growth of 3.8% and sales of €509 million. Within Scent & Care, high-single-digit growth in consumer fragrance and aroma molecules offset a mid-single-digit percentage decline in fine fragrance.

Sample IUX Markets – In-articleAd

Geographically, Symrise saw strong momentum in key overseas markets, which compensated for softness in Europe. Growth in the Asia Pacific region was particularly strong at 12.3%, while North America grew by 9.6%. This contrasted with declines in the EAME (Europe, Africa, Middle East) region of 0.4% and Latin America of 2.1%.

Outlook and Financial Health

Symrise maintained its full-year 2026 guidance, reaffirming its target for organic sales growth of 2% to 4% and an adjusted EBITDA margin between 21.5% and 22.5%. The company also stated it expects third-quarter organic sales growth to be similar to the level seen in the second quarter.

The company's financial position strengthened in the first half of the year. Business free cash flow increased to €347 million from €226 million in the same period of 2025. Net financial debt stood at €2,303 million, representing a net debt to EBITDA ratio of 2.2 times.

Read next

More on Stocks
Back to latest news

LATEST